Cumulative Kushco Holdings Inc 's Working Capital Ratio for Trailing Twelve Months Period

KSHB's Working Capital Ratio for Trailing Twelve Months Period and Current Assets, Current Liabilities growth

Select the Comparisons :

None ▼

Select the Ratio:

Working Capital Ratio for Trailing Twelve Months Period ▼

None ▼

Working Capital Ratio for Trailing Twelve Months Period ▼

KSHB Working Capital Ratio for Trailing Twelve Months Period	(May 31 2021) III. Quarter	(Feb 28 2021) II. Quarter	(Nov 30 2020) I. Quarter	(Aug 31 2020) IV. Quarter	(May 31 2020) III. Quarter
Y / Y Current Liabilities Growth	12.65 %	935.46 %	173.03 %	7.8 %	-32.4 %
Y / Y Current Assets Growth	23.01 %	57.96 %	-32.9 %	-33.63 %	-33.22 %
Working Capital Ratio for Trailing Twelve Months Period	2.2	2.14	2.73	4.37	4.95
Total Ranking	# 2217	# 2314	# 2026	# 1522	# 1297
Seq. Current Liabilities Growth	-53.81 %	13.78 %	72.83 %	24.01 %	324.58 %
Seq. Current Assets Growth	-29.65 %	62.2 %	17.16 %	-7.99 %	-9.66 %

KSHB Segments >> Back to KSHB Financial Strength Comparisons >> Compare KSHB Debt to Equity Ratio to its Competitors

Working Capital Ratio for Trailing Twelve Months Period Comment for 12 Months ending at May 31 2021

On the trailing twelve months basis Kushco Holdings Inc Current Assets average grew by 23.01% in III. Quarter year on year, faster than Current Liabilities, this led to increase in in Kushco Holdings Inc 's Working Capital Ratio for Trailing Twelve Months Period to 2.2, Working Capital Ratio for Trailing Twelve Months Period remained below Kushco Holdings Inc average.
Working Capital Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Medical Laboratories industry 20 other companies have achieved higher Working Capital Ratio for Trailing Twelve Months Period than Kushco Holdings Inc . While overall ranking remained unchanged compare to previous quarter at no. .

What is Working Capital Ratio?
More about KSHB
Working Capital Ratio KSHB in the most recent quarter

Working Capital Ratio for Trailing Twelve Months Period Company Ranking
Within:	No.
Industry	# 21
Sector	# 627
S&P 500	# 1389

Working Capital Ratio for Trailing Twelve Months Period Statistics
High	Average	Low
3.66	2.75	1.98
(Feb 28 2017)		(Feb 28 2021)

Companies with similar average Working Capital Ratio for Trailing Twelve Months Period for 12 months ending May 31 2021, within Medical Laboratories Industry	Working Capital Ratio for Trailing Twelve Months Period
Fulgent Genetics Inc	5.44
Natera inc	5.07
Absci Corp	4.57
Miragen Therapeutics Inc	4.52
Incyte Corporation	3.81
Exact Sciences Corporation	3.80
Opgen inc	3.72
Biocept Inc	3.68
Luna Innovations Inc	3.54
Psychemedics Corporation	3.44
Vyant Bio Inc	3.13
Hh and l Acquisition Co	2.89
Ispecimen inc	2.86
Bionexus Gene Lab Corp	2.83
Medpace Holdings Inc	2.73
Enzo Biochem Inc	2.63
Kushco Holdings Inc	2.60
National Research Corporation	2.38
Biodesix Inc	2.18
Charles River Laboratories International inc	2.06
Hologic Inc	1.83
Nano x Imaging Ltd	1.80
Evolutionary Genomics Inc	1.70
Laboratory Corporation Of America Holdings	1.62
American Shared Hospital Services	1.60
Iqvia Holdings Inc	1.59
Quest Diagnostics Inc	1.57
Koninklijke Philips Nv	1.42
Icon Plc	1.40
Centogene N v	1.30

Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Cumulative Kushco Holdings Inc 's Working Capital Ratio for Trailing Twelve Months Period

KSHB Working Capital Ratio for Trailing Twelve Months Period